Market Cap | 20.24M | P/E | - | EPS this Y | 10.00% | Ern Qtrly Grth | - |
Income | -35.76M | Forward P/E | -0.15 | EPS next Y | 18.90% | 50D Avg Chg | -5.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | 0.61 | EPS next 5Y | - | 52W High Chg | -30.00% |
Recommedations | 2.00 | Quick Ratio | 2.69 | Shares Outstanding | 1.46M | 52W Low Chg | 7.00% |
Insider Own | 10.88% | ROA | -81.25% | Shares Float | 883.64K | Beta | 1.45 |
Inst Own | 55.85% | ROE | -170.91% | Shares Shorted/Prior | 3.37K/0.93K | Price | 0.96 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 69,356 | Target Price | 112.50 |
Oper. Margin | - | Earnings Date | Nov 11 | Volume | 662,432 | Change | -4.80% |
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Chardan Capital | Buy | Aug 19, 24 |
Brookline Capital | Buy | May 30, 24 |
Ladenburg Thalmann | Buy | Apr 8, 24 |
Chardan Capital | Neutral | Sep 20, 21 |
Brookline Capital | Hold | Sep 3, 21 |
Chardan Capital | Sell | Sep 3, 21 |
Ladenburg Thalmann | Neutral | Sep 3, 21 |
B. Riley Securities | Neutral | Sep 3, 21 |
Truist Securities | Hold | Sep 3, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Wagner Paul A. | See Remarks See Remarks | Dec 18 | Buy | 0.7525 | 10,000 | 7,525 | 1,823,236 | 12/20/23 |
Wagner Paul A. | See Remarks See Remarks | Dec 13 | Buy | 0.71 | 20,520 | 14,569 | 1,813,236 | 12/15/23 |
Wagner Paul A. | See Remarks See Remarks | Dec 11 | Buy | 0.65 | 29,776 | 19,354 | 1,792,716 | 12/12/23 |
Wagner Paul A. | See Remarks See Remarks | Dec 07 | Buy | 0.6 | 51,203 | 30,722 | 1,762,940 | 12/08/23 |
Wagner Paul A. | See Remarks See Remarks | Nov 20 | Buy | 0.43 | 7,366 | 3,167 | 1,711,737 | 11/22/23 |